{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-064467","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.179628+00:00","generated_at":"2026-05-18T06:14:31.238748+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Adial Pharmaceuticals regains Nasdaq compliance with stockholders' equity requirement after $3.6M offering","bullets":["Nasdaq confirmed compliance with Listing Rule 5550(b)(1) as of July 14, 2025.","Deficiency arose from $2.13M equity as of Mar 31, 2025, below $2.5M minimum.","June 2025 best-efforts offering raised ~$3.6M gross via shares and warrants.","Nasdaq will monitor ongoing compliance; next periodic report may trigger re-evaluation."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-064467","json":"https://secwatch.observer/filing/0001213900-25-064467.json","markdown":"https://secwatch.observer/filing/0001213900-25-064467.md","text":"https://secwatch.observer/filing/0001213900-25-064467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025064467/0001213900-25-064467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025064467/ea0249089-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:14:31.238748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}